Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

689
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
689
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

77
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
77
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

635
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
635
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

66
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
66

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Circumventing the Synthesizability Problem in Generative Molecular Design.

Journal of chemical information and modeling·2026
Same author

Sequence-based modeling of low-affinity transcription factor-DNA binding through deep learning.

NAR genomics and bioinformatics·2026
Same author

Circumventing the synthesizability problem in generative molecular design.

bioRxiv : the preprint server for biology·2026
Same author

Quantitative modulation of a spatial enhancer through the biophysical properties of a transcription factor binding site.

Science advances·2026
Same author

Novel fold and wing structure of Forkhead transcription factor facilitate DNA binding.

Nucleic acids research·2025
Same author

PAM-adjacent DNA flexibility tunes CRISPR-Cas12a off-target binding.

Scientific reports·2025

相关实验视频

Updated: Jun 19, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.6K

基于结构的药物设计,具有深层次的生成模型.

Jesse A Weller1,2, Remo Rohs1,2,3,4

  • 1Department of Quantitative and Computational Biology, University of Southern California, Los Angeles, California 90089, United States.

Journal of chemical information and modeling
|July 26, 2024
PubMed
概括
此摘要是机器生成的。

DrugHIVE是一种新型的深层次变异自编码器,通过比现有方法更快地产生高质量的分子来加速药物设计. 这种可扩展的方法增强了虚拟查,并帮助各种药物发现任务,即使是以前无法访问的目标.

更多相关视频

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.0K

相关实验视频

Last Updated: Jun 19, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.6K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.0K

科学领域:

  • 计算化学的计算化学
  • 药物发现 药物发现 药物发现
  • 机器学习 机器学习

背景情况:

  • 扩大化学图书馆和改进的虚拟选方法对早期药物设计产生了影响.
  • 基于选的方法仍然存在可扩展性限制,原因是计算限制和庞大的化学空间.
  • 机器学习模型从数据中学习药物目标关系,以克服这些局限性.

研究的目的:

  • 介绍DrugHIVE,一个用于增强分子生成的深层次变异自编码器.
  • 与最先进的生成模型相比,展示DrugHIVE的优越速度和性能.
  • 强调DrugHIVE对广泛的药物设计任务和目标的适用性.

主要方法:

  • 开发了DrugHIVE,这是一个深层次的变量自编码器架构.
  • 根据标准生成基准对自回归和扩散模型进行评估DrugHIVE.
  • 评估DrugHIVE在虚拟查效率和各种药物设计任务中的表现.

主要成果:

  • 在生成基准上,DrugHIVE在速度和性能方面超过了最先进的方法.
  • 层次设计为分子生成提供了更好的控制.
  • 该方法证明了可扩展性和适用于AlphaFold预测结构的适用性.

结论:

  • 通过有效的,可控的分子生成,DrugHIVE显著加速了药物设计.
  • 该方法增强了虚拟选,并支持各种任务,如de novo设计和脚手架跳跃.
  • 药物HIVE将高质量的类似药物的分子生成扩展到大多数人体蛋白质组,包括以前难以处理的目标.